Check out what’s being clicked on FoxBusiness.com
Billionaire CEO Elon Musk said the first human to receive Neuralink’s cybernetic implant received it on Sunday and is recovering well.
In September, Neuralink announced that it would be recruiting for a first-in-human clinical trial of its wireless brain-computer interface (BCI).
Neuralink said in an announcement that the Precision Robotic Implantable Brain-Computer Interface (PRIME) study will assess the safety of its implants (N1) and surgical robots (R1), and that the device will Said to evaluate whether it helps people control external devices. thought.
On Sunday, the first implant was placed in a human.
“The first human received an implant from @Neuralink yesterday and is recovering well,” Musk tweeted on his social media platform “It was done,” he said.
Elon Musk says first human patient will soon receive Neuralink brain implant
This multiple exposure illustrated photo taken on December 10, 2021 in Krakow, Poland, shows the Neuralink logo displayed on a mobile phone screen, a paper silhouette in the shape of a human face, and an image displayed on the screen. You can see the binary code. (Jakub Porzycki/NurPhoto via Getty Images)
The tech mogul also tweeted that the first version of Neuralink is called Telepathy, which will allow people to control their phones, computers, and almost any device through them just by thinking. explained.
“The first users will be people who have lost the use of their limbs,” Musk said. “Imagine if Stephen Hawking could communicate faster than a speed typist or an auctioneer. That’s the goal.”
Elon Musk’s brain implant technology receives FDA approval
The late theoretical physicist Hawking suffered from Lou Gehrig’s disease, a rare disease that causes paralysis.
In May, Neuralink received approval from the Food and Drug Administration (FDA) to proceed with human trials of its brain implant.
Elon Musk is “confident” about Neuralink microchip device, plans to start human trials within six months
Elon Musk, chief executive officer of Neuralink, SpaceX, Tesla and owner of Twitter, speaks at the Innovation and Startup Special Conference held at the Porte de Versailles Exhibition Center in Paris, France, on June 16. Attending the Viva Technology Conference and gesturing. (Reuters/Gonzalo Fuentes/File Photo/Reuters Photo)
Musk had been seeking approval for human trials since 2019, but Neuralink’s application was rejected in early 2022. The company has since addressed concerns expressed by the FDA regarding the safety of the implant.
Musk launched Neuralink in 2016 with the goal of developing chips that would allow the brain to control complex electronic devices and ultimately restore motor function to people with paralysis.
Click here to read more on FOX Business
If successful, the technology will combine artificial intelligence and human capabilities through the use of brain chips. Musk said he hopes this will help treat brain diseases such as Parkinson’s disease, dementia and Alzheimer’s disease.
Fox News Digital’s Chris Pandolfo contributed to this report.
